Atherosclerosis: The Silent Killer of Cardiovascular Disease

Atherosclerosis, a condition characterized by the buildup of plaque in the arterial walls, affects over 100 million people worldwide, with a staggering 17.9 million deaths attributed to cardiovascular disease annually. The disease progresses slowly, often without noticeable symptoms, until a critical blockage occurs, leading to heart attacks, strokes, and other severe complications. Researchers like Dr. Russell Ross and Dr. Michael Brown have made significant contributions to understanding the pathogenesis of atherosclerosis, highlighting the interplay between lipid metabolism, inflammation, and endothelial dysfunction. Despite advances in medical therapy and surgical interventions, atherosclerosis remains a leading cause of morbidity and mortality globally, with the World Health Organization (WHO) estimating that 37% of all deaths worldwide are due to cardiovascular disease. The economic burden of atherosclerosis is substantial, with estimated annual costs exceeding $500 billion in the United States alone. As the population ages and risk factors such as obesity, diabetes, and hypertension continue to rise, the incidence of atherosclerosis is expected to increase, underscoring the need for continued research, improved prevention strategies, and innovative treatments to combat this silent killer.